Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Cancer Science|April 12, 2013
Phase I/II study of bortezomib-melphalan-prednisolone for previously untreated Japanese patients with multiple myelomaYoshiaki Ogawa, Kenshi Suzuki, Akira Sakai, et al.
Cancer Science|July 21, 2007
Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004Kensei Tobinai, Kunihiko Takeyama, Fumito Arima, et al.
Blood|August 7, 2004
Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarctionHiroshi Kawada, Jun Fujita, Kentaro Kinjo, et al.
Cancer Science|November 1, 2007
Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myelomaYoshiaki Ogawa, Kensei Tobinai, Michinori Ogura, et al.
Stem Cells (Dayton, Ohio)|August 11, 2007
Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repairJun Fujita, Mitsuharu Mori, Hiroshi Kawada, et al.
Cancer Science|July 15, 2009
Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphomaKensei Tobinai, Ken-ichi Ishizawa, Michinori Ogura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trialTakashi Watanabe, Kensei Tobinai, Taro Shibata, et al.
Leukemia & Lymphoma|April 7, 2010
Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T/natural killer-cell lymphomasTakashi Watanabe, Tomohiro Kinoshita, Kuniaki Itoh, et al.
Japanese Journal of Clinical Oncology|September 22, 2006
Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding studyYasuo Morishima, Michinori Ogura, Shuichi Yoneda, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|July 1, 2021
A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphomaKazunori Ohnishi, Ken Ohmachi, Kiyoshi Ando, et al.
Pageof 12